After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...

Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

In a 19-page letter to GSK chairman Sir Jonathan Symonds, Elliott said it had previously held off from sharing its thoughts about GSK publicly to allow the company to focus on the 23 June investor ...

AZ has confirmed that the US regulator issued a complete response letter (CRL) for PT010, a triple therapy for COPD that would compete with GSK’s already-marketed Trelegy. A spokesman for AZ tol ...